@inproceedings{inproceedings, title  = {{AZD5363, an AKT inhibitor, significantly inhibits key biomarkers of the AKT pathway and Ki67, in a randomized, placebo, controlled study (STAKT) in human breast cancers}},

 url = {{}},

 year = {{2018}},

 month = {{1}},

 author = {{Robertson JFR and Coleman RE and Cheung KL and Evans A and Holcombe C and Skene A and Rea D and Ahmed S and Jahan A and Kelly S and Horgan K et al}},

 volume = {{78}},

 journal = {{CANCER RESEARCH}},

 issue = {{4}},

 note = {{Accessed on 2025/10/10}}}